UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 155 filers reported holding UNIQURE NV in Q2 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,037,000 | -86.5% | 50,000 | -79.1% | 0.06% | -80.1% |
| Q3 2021 | $7,668,000 | +3.9% | 239,548 | 0.0% | 0.31% | +24.3% |
| Q2 2021 | $7,378,000 | -12.4% | 239,548 | -4.2% | 0.25% | +33.5% |
| Q1 2021 | $8,422,000 | -6.8% | 250,000 | 0.0% | 0.19% | -12.6% |
| Q4 2020 | $9,032,000 | -24.5% | 250,000 | -23.1% | 0.22% | -53.3% |
| Q3 2020 | $11,970,000 | -40.2% | 325,000 | -26.8% | 0.46% | -39.8% |
| Q2 2020 | $20,014,000 | +68.7% | 444,157 | +77.7% | 0.76% | +38.7% |
| Q1 2020 | $11,863,000 | -58.6% | 250,000 | -37.5% | 0.55% | -51.8% |
| Q4 2019 | $28,664,000 | -19.1% | 400,000 | -55.6% | 1.14% | -46.9% |
| Q3 2019 | $35,424,000 | -35.2% | 900,000 | +28.6% | 2.16% | -31.4% |
| Q2 2019 | $54,705,000 | – | 700,000 | – | 3.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |